Treatment of LnCl 3 with three molar equivalents of LiL [(L = N-(2-methoxyphenyl)-N-(trimethylsilyl)amide (L 1 ) or N-(2-phenoxyphenyl)-N-(trimethylsilyl)amide (L 2 )], generated in situ from LH and nBuLi, or with the isolated lithium complex [Li(L 1 )(OEt 2 )] 2 (for Ln = Yb) in THF afforded the solvent-free homoleptic complexes [Ln(L) 3 ] [Ln = Yb (1a), Er (1b), Sm (1c), Pr (1d), Nd (1e), L = L 1 ; Ln = Yb (2a), Y (2b), Sm (2c), Nd (2d), La (2e), L = L 2 ). With a 2:1 LiL (generated in situ) to LnCl 3 molar ratio, the solvent-free heteroleptic complexes [Ln(L) 2 (µ-Cl)] 2 were obtained for L = N,N-dimethyl-NЈ-trimethylsilylethane-1,2-diaminate (enЈ) [Ln = Yb (3a), Er (3b), Sm (3c), Nd (3d), La (3e)], but not for L 1 or L 2 , which gave [Ln(L) 3 ] [Ln = Yb (1a), Nd (1e), L = L 1 ; Ln = Yb (2a), Nd (2d), La (2e), L = L 2 ]. However, treatment of LnCl 3 with two molar equivalents of the isolated crystalline lithium salt [Li(L 1 )(-OEt 2 )] 2 in THF gave, for the heavier lanthanoids, the solventfree heteroleptic complexes [Ln(L 1 ) 2 (µ-Cl)] 2 [Ln = Yb (4a), Er (4b), Tb (4c)], although the homoleptic complex [Nd(L 1 ) 3 ] (1e)